
Current vaccines against mpox were designed to fight an older, rarer cousin of the virus, smallpox. Now, new research from the drug company Moderna suggests its new mpox vaccine, based on mRNA technology, might do a better job at shielding recipients from harm. The findings were published Sept. 4 in the journal Cell. “With the… read on > read on >